Dow Jones U.S. Select Pharmaceuticals Index Forecast

Outlook: Dow Jones U.S. Select Pharmaceuticals index is assigned short-term B2 & long-term Ba3 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic¹ :
Dominant Strategy :
Time series to forecast n: for Weeks²
ML Model Testing : Multi-Task Learning (ML)
Hypothesis Testing : Pearson Correlation
Surveillance : Major exchange and OTC

¹Short-term revised.

²Time series is updated based on short-term trends.

Key Points

This exclusive content is only available to premium users.

About Dow Jones U.S. Select Pharmaceuticals Index

The Dow Jones U.S. Select Pharmaceuticals Index is a significant benchmark designed to track the performance of leading publicly traded companies engaged in the pharmaceutical industry within the United States. This index is meticulously constructed to represent a broad spectrum of the pharmaceutical sector, encompassing companies involved in research, development, manufacturing, and distribution of prescription drugs, biotechnology products, and related healthcare services. Its composition is carefully curated to reflect the market capitalization and business activities of these key players, providing investors with a clear gauge of the industry's overall health and trends.

The index serves as a valuable tool for financial professionals and investors seeking to understand and participate in the U.S. pharmaceutical market. By focusing on a select group of prominent companies, it aims to offer a more targeted and representative view of the pharmaceutical sector's economic impact and investment potential. The selection methodology emphasizes companies with substantial market presence and a demonstrable commitment to innovation within the healthcare landscape, making it a crucial indicator for analyzing sector-specific performance and strategic shifts.

This exclusive content is only available to premium users.

ML Model Testing

F(Pearson Correlation)^6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Multi-Task Learning (ML))^3,4,5 X S(n):→ 3 Month $\sum _{i=1}^n\left(s_i\right)$

n:Time series to forecast

p:Price signals of Dow Jones U.S. Select Pharmaceuticals index

j:Nash equilibria (Neural Network)

k:Dominated move of Dow Jones U.S. Select Pharmaceuticals index holders

a:Best response for Dow Jones U.S. Select Pharmaceuticals target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

Dow Jones U.S. Select Pharmaceuticals Index Forecast Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.

Rating	Short-Term	Long-Term Senior
Outlook	B2	Ba3
Income Statement	Baa2	Baa2
Balance Sheet	C	B3
Leverage Ratios	C	B1
Cash Flow	Baa2	B2
Rates of Return and Profitability	C	Ba2

*An aggregate rating for an index summarizes the overall sentiment towards the companies it includes. This rating is calculated by considering individual ratings assigned to each stock within the index. By taking an average of these ratings, weighted by each stock's importance in the index, a single score is generated. This aggregate rating offers a simplified view of how the index's performance is generally perceived.
How does neural network examine financial reports and understand financial state of the company?

References

1. Van der Vaart AW. 2000. Asymptotic Statistics. Cambridge, UK: Cambridge Univ. Press
2. Belsley, D. A. (1988), "Modelling and forecast reliability," International Journal of Forecasting, 4, 427–447.
3. R. Howard and J. Matheson. Risk sensitive Markov decision processes. Management Science, 18(7):356– 369, 1972
4. M. Benaim, J. Hofbauer, and S. Sorin. Stochastic approximations and differential inclusions, Part II: Appli- cations. Mathematics of Operations Research, 31(4):673–695, 2006
5. M. Ono, M. Pavone, Y. Kuwata, and J. Balaram. Chance-constrained dynamic programming with application to risk-aware robotic space exploration. Autonomous Robots, 39(4):555–571, 2015
6. R. Sutton and A. Barto. Reinforcement Learning. The MIT Press, 1998
7. O. Bardou, N. Frikha, and G. Pag`es. Computing VaR and CVaR using stochastic approximation and adaptive unconstrained importance sampling. Monte Carlo Methods and Applications, 15(3):173–210, 2009.